Harvard Bioscience Cash Flow - Annual (NASDAQ:HBIO)

Add to My Stocks
$2.78 $0.02 (0.89%) HBIO stock closing price Aug 22, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Harvard Bioscience needs to disclose. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Harvard Bioscience profits one has to check the income statement and for Harvard Bioscience debt one has to check the balance sheet. Harvard Bioscience stock analysis shows negative net income cash flow of $-4.3M for 2016. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   HBIO increase in investments stood at a negative value of $-0.06M for the latest 2016. View details of Harvard Bioscience cash flows for latest & last ten financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
Harvard Bioscience Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow4.36M4.65M3.93M4.03M4.25M4.41M4M3.45M3.36M3.47M
Net Increase (Decrease) in Assets Liabilities-0.04M-2.71M-4.51M1.94M0.25M-3.85M-1.23M5.2M-1.56M2.01M
Cash From (used in) Discontinued Operations----0.44M-1.34M---3.28M3.08M
Other Adjustments Net5.36M17.8M2.57M0.35M2.52M2.27M-9.49M0.61M2.44M4.83M
Harvard Bioscience Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-1.44M-2.95M-0.86M-1.55M-1.73M-1.48M-0.81M-1.37M-1.3M-1.45M
Acquisition Disposition of Subsidiaires1.41M-4.54M-12.65M1.78M-2.87M-5.46M-7.11M-20.76M-0.75M-5.08M
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities-0.03M-0.01M--0.05M-0.06M-0.25M-0.41M-0.16M-0.56M-0.01M
Harvard Bioscience Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares0.18M2.04M2.06M3.62M2.28M0.56M-4.71M-2.13M-1.68M0.72M
Issuance (Repayment) of Debt Securities-5.05M5.8M-3.3M11.8M-3.35M-1.7M4.68M13.22M-6.27M2.47M
Increase (Decrease) in Bank & Other Borrowings--8.35M------1.3M--0.16M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--0.03M--15.35M------
Harvard Bioscience Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-1.6M-0.03M-1.23M0.79M0.44M-0.09M-0.8M-1.1M-3.12M-0.08M
Harvard Bioscience Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M18.2M9.75M
Cash & Equivalents at Year End5.59M6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M18.2M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Harvard Bioscience stock price history and Harvard Bioscience stock comparison chart inevitably reflect its cash flow situation.
  • Harvard Bioscience saw an increase in Net Change in Cash and Cash Equivalents from $-7.39M in 2015 to $-1.14M in 2016. Apart from the Harvard Bioscience stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Harvard Bioscience reported a positive operating cash flow of $5.38M for 2016 and has seen an increase from the previous year. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $5.38M for HBIO in last year report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Harvard Bioscience spent $4.32M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.